Severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 is an emerging disease with fatal outcomes. In this study a fundamental knowledge gap question is to be resolved by evaluating the differences in biological and pathogenic aspects of SARS-CoV-2 and the changes in SARS-CoV-2 in comparison with the two prior major COV epidemics SARS and Middle East respiratory syndrome MERS coronaviruses. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.